Free fatty acid metabolism during myocardial ischemia and reperfusion

Molecular and Cellular Biochemistry

Volumn 166, Issue 1-2, 1997, Pages 85-94

  Hendrickson, Steven C ^a   St Louis, James D ^a   Lowe, James E ^a   Abdel aleem, Salah ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Myocardial ischemia; Myocardial metabolism; Nonesterified fatty acids; Reperfusion injury

Indexed keywords

ACYLCARNITINE; FATTY ACID; GLUCOSE; THIOESTER;

AEROBIC METABOLISM; ARTICLE; CARDIOTOXICITY; CORONARY ARTERY DILATATION; ELECTRON TRANSPORT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; SARCOLEMMA; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HEART; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

ANIMALIA;

EID: 0031045198     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006886601825     Document Type: Article

References (97)

1. Oliver MF, Kurien VA, Greenwood TW: Relation between serum free-fatty acids and arrythmias and death after acute myocardial infarction. Lancet 1: 710-715, 1968
2. Gupta DK, Jewitt DE, Young R, Hartog M, Opie LH: Increased plasma-free-fattyacid concentrations and their significance in patients with acute myocardial infarction. Lancet 2: 1209-1213, 1969
3. Storstein L, Nitter-Hauge S, Fjeld N: Effects of cardiopulmonary bypass with heparin administration on digoxin pharmacokinetics, serum electrolytes, free fatty acids and renal function. J Cardiovasc Pharm 1: 191-204, 1979
4. Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol 36: 938-953, 1975
5. Svennson S, Svedjeholm R, Ekroth R, Milocco I, Nilsson F, Sabel KG, WilliamOlsen G: Trauma metabolism and the heart. J Thorac Cardiovasc Surg 99: 1063-1073, 1990
6. Lopaschuk GD, Collins-Nakai P, Olley PM, Montague TJ, McNeil G, Gayle M, Penkaske P, Finegan BA: Plasma free fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128: 61-67, 1994
7. Reves JG, Karp RB, Buttner EE, Tosone S, Smith LR, Samuelson PN, Kreusch GR, Oparil S: Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 66: 49-55, 1982
8. Molaparast-Saless F, Liedtke AJ, Nellis SH: Effects of fatty acid blocking agents oxfenicine and 4-bromocrotonic acid in aerobic and ischemic myocardium. J Mol Cell Cardiol 19: 509-520, 1987
9. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of the heart. Ann Rev Physiol 36: 413-459, 1972.
10. Van der Vusse GJ, Glatz JF, Stam HCG, Reneman R: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881-940, 1992
11. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23: 321-336, 1981
12. Knudsen J, Mandrup S, Rasmusscn JT, Andreasen PH, Poulsen F, Kristiansen K: The function of acyl-CoA-binding protein (ACBP)/ diazepam binding inhibitor (DBI). Mol Cell Biochem 123: 129-138, 1993
13. Waku K: Origins and fates of fatty acyl-CoA esters. Biochim Biophys Acta 1124: 101-111, 1992
14. Fournier NC, Rahim M: Control of energy production in the heart: a new function for fatty acid binding protein Biochem 24: 2387-2396, 1985
15. Lopashuck GD, Belke DD, Gamble J, Itoi T, Schonekess BO: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-270, 1994
16. Saddik M, Lopaschuk GD: Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266: 8162-8170, 1991
17. Murthy MSR, Pande SV: Malonyl-CoA binding site and the overt carnitine palmitoyltraansferase activity reside on the opposite sides of the outer mitochondrial membrane. Proc Natl Acad Sci 84: 378-382, 1987
18. Schulz H: Regulation of fatty acid oxidation in heart. J Nutr 124: 165-171, 1994
19. Olowe Y, Schulz H: Regulation of thiolases from pig heart. Control of fatty acid oxidation in heart. Eur J Biochem 109: 425-429, 1980
20. Forster ME, Staib W: β-oxidation as a channeled reaction linked to the citric acid cycle: evidence from measurements of mitochondrial pyruvate oxidation during fatty acid degradation, Int J Biochem 24: 1111-1116, 1992
21. Sumeji B, Porpaczy Z, Alkonyi I: Kinetic advantage of the interaction between the fatty acid β-oxidation enzymes and the complexes of the respiratory chain. Biochim Biophys Acta 1081: 121-128, 1991
22. 14C] hexadecanoate oxidation by intact rat liver mitochondria. Biochem J 262: 261-269, 1989
23. Nada MA, Rhead WJ, Sprecher H, Schulz H, Roe CR: Evidence for intermediate channeling in mitochondrial β-oxidation. J Biol Chem 270: 530-535, 1995
24. Opie LH: Fuels: carbohydrates and lpids. in: The heart: physiology and metabolism. 2nd ed. Raven Press, New York, 1991, pp 208-246
25. Pearce FJ, Forster J, DeLeeuw G, Williamson JR, Tutwiler GF: Inhibition of fatty acid oxidation in normal and hypoxic perfused rat hearts by 2-tetradecylglycidic acid. J Mol Cell Cardiol 11: 893-915, 1979
26. Hutter JP, Schweickhardt C, Piper HM, Spieckerman PG: Inhibition of fatty acid oxidation and decrease of oxygen consumption of working rat heart by 4bromocrotonic acid. J Mol Cell Cardiol 16: 105-108, 1984
27. Randle PJ, Garland PB, Hales CM, Newsholme EA: The glucosefatty acid cycle: its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963
28. Saddik M, Gamble J, Witters LA, Lopaschuk GD: Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993
29. Lysiak W, Toth PP, Suelter CH, Bieber LL: Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria. J Biol Chem 261: 13698-13703, 1986
30. Cook GA: Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in Ki values. J Biol Chem 259: 12030-12033, 1984
31. Uziel G, Garavaglia B, DiDonato S: Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11: 720-724, 1988
32. Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart J Biol Chem 267: 3758-3763, 1992
33. Ahdel-alepm S, Sayed-Ahmed M, Nada M, Hendriekson SC, St. Louis JD, Walthall HP, Lowe JE: Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes. J Mol Cell Cardiol (in press)
34. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Progress CV Dis 23: 321-336, 1981
35. Van Bilsen M, van der Vusse GJ, Willemsem PHM, Coumans WA, Roemen THM, Reneman RS: Lipid alterations in isolated, working rat hearts during ischemia and reperfusion: its relation to myocardial damage. Cire Res 64: 304-314, 1989
36. Lowe JE, Jennings RB, Reimer KA: Cardiac rigor mortis in dogs. J Mol Cell Cardiol 11: 1017-1031, 1979
37. Weiss J, Hiltbrand B: Functional compartmentalization of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest 75: 436-447, 1985
38. Owen P, Dennis S, Opie LH: Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 66: 344-354, 1990
39. Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhipenko YV: The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 77: 465-485, 1982
40. Mak IT, Kramer JH, Weslicki WB: Potentiation of free radicalinduced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles. J Biol Chem 261: 1153-1157, 1986
41. Liedtke AJ, Mahar CQ, Ytrehus K, Mjos OD: Estimates of freeradical production in rat and swine hearts: method and application of measuring malondialdchyde levels in fresh and frozen myocardium. Bas Res Cardiol 79: 513-518, 1984
42. Schwaiger M, Schelbert HR, Keen R, Vinten-Johansen J, Hanser H, Selin C, Barrio J, Huang SC, Phelps ME: Retention and clearance of C-11 palmitate in ischemic and reperfused canine myocardium, J Am Coll Cardiol 6: 311-320, 1985
43. Schwaiger M, Scheibert HR, Ellison D, Hansen H, Yeatman L, Vinten-.Johansen .J, Selin C, Barrie J, Phelps ME: Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model, J Am Coll Cardiol 6: 336-347, 1985
44. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH: Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 62: 535-542, 1988
45. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546-553, 1990
46. Gorge G, Chatelain P, Schaper J, Lerch R: Effect of increasing degrees of ischcmic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res 68: 1681-1692, 1991
47. Saddik M, Lopaschuk CD: Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 267: 3825-3831, 1992
48. Liedtke AJ, Nellis SH, Neely JR: Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res 43: 652-661, 1978
49. Katz AM, Mesineo FC: Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1-16, 1981
50. Raz A, Livne A: Differential effects of lipids on the osmotic fragility of erythrocytes, Biochim Biophys Acta 311: 222-229, 1973
51. +-ATPase and sarcoplasmic reticulum calcium ATPase and calcium transport. J Biol Chem 254: 12404-12410, 1979
52. Dhalla NS, Kolar F, Shah KR, Ferrari R: Effects of some Lcarnitine derivatives on heart membrane ATPases. Cardiovasc Drugs Ther 5: 25-30, 1991
53. Osornio-Vargas AR, Berezesky JK, Trump BF: Progression of ion movements during acute myocardial infarction in the rat. An X-ray microanalysis study Scan Electron Microse. 2: 463-472, 1981
54. 2+ transport. J Biol Chem 264: 12404-12410, 1979
55. +-ATPase and adenylate cyclase activity of canine myocardial sarcolemma. J Mol Cell Cardiol 16: 239-245, 1984
56. Shug AL, Shrago E, Bittar N, Folts JD, Koke JR: Acyl-CoA inhibition of adenine nucleotide translocase in ischemic myocardium. Am J Physiol 228: 689-692, 1975
57. Wolkowicz PE, Pownall HJ, McMillan-Wood JB: (1-Pyrenebutyryl)carnitine and 1-pyrenebutyryl coenzyme A: fluorescent probes for lipid metabolite studies in artificial and natural membranes. Biochemistry 21: 2990-2996, 1982
58. Wojtczak L: Effect of fatty acids and acyl-CoA on the permeability of mitochondrial membranes to monovalent cations. FEBS Lett 44: 25-30, 1974
59. +-ATPase by palmitoylcarnitine and palmitoylCoA. Biochim Biophys Res Commun 74: 677-084, 1977
60. Shrago E: Myocardial adenine nucleotide translocase. J Mol Cell Cardiol 8: 497-500, 1976
61. Messino FC, Rathier M, Favreau C, Wattras J, Takenaka H: Mechanisms of fatty acid effects on sarcoplasmic rericulum III The effects of palmitic and oleic acids on sarcoplasmic reticulum function - a model for fatty acid membrane interactions, J Biol Chem 259: 1336-1343, 1984
62. Steigen TK, Aasum E, Myrmel T, Larsen TS: Effects of fatty acids on myocardial calcium control during hypothermie perfusion. J Thorac Cardiovasc Surg 107: 233-241, 1994
63. Watras J, Messineo FC, Herbette LG: Mechanisms of fatty acid effects o n sarcoplasmic reticulum: I. calcium-fatty acid interaction. J Biol Chem 259: 1319-1324, 1984
64. Feuvray D, Plouet J: Relationship between structure and fatty acid metabolism in mitochondria isolated from ischemic rat hearts. Circ Res 48: 740-747, 1981
65. Lamers JJM, De Jonge-Stinis JT, Verdouw PD, Hulsmann WC: On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischemia. Cardiovasc Res 21: 313-322, 1987
66. + ATPase. Am J Physiol 247: H840-H846, 1984
67. Weiss JN, Lamp ST: Glycolysis preferentially inhibits ATP-sensitive K' channels in isolated guinea pig cardiomyocytes. Science 238: 67-69, 1987
68. Hardin C, Raeymakers L, Wuytack F, Casteels R, Paul RJ: An endogenous glycolytic cascade can preferentially fuel Ca2+- uptake in a plasma membrane vesicle fraction(PMV) of smooth muscle. Fed Proc 46: 1096, 1987, [Abstract]
69. Apstein CS, Gravino FN, Haudenschild CC: Determinants of the protective effect of glucose and insulin in ischemic myocardium: effects on contractile function, diastolic compliance, metabolism and ultrastructure during ischemia and reperfusion. Circ Res 52: 515-526, 1983
70. Marako PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Correl JW, Braunwald E: Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circ 45: 1160-1175, 1972
71. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ: Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 60: 411-416, 1995
72. Neely JR, Grotyoharm LW: Rule of glycolyric products in damage to ischemic myocardium. Cire Res 55: 816-824, 1984
73. MeVeigh JJ, Lopaschuk GD: Dichloroacetate stimulation of glu cose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259: H1079-H1085, 1990
74. Lopaschuk GD, Wall SR, Olley PM, Davies NJ: Etoxomir, a carnitine palmitoyltransferase inhibitor, protects hearts from fatty-acid induced ischemic injury independent of changes in longchain acylcarnitine. Circ Res 63: 1036-1043, 1988
75. Jummy RW, Ambrosio G, Pike MM, Jacobus WE, Becker LC: The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion. J Mol Cell Cardiol 25: 261-276, 1993
76. Gradinac S, Coleman GM, Taegtmeyer H, Sweeney MS, Frazier OH: Improved cardiac function with glucose-insulin-potassium after aortoeoronary bypass grafting. Ann Thorac Surg 48: 484-489, 1989
77. Huang XQ, Liedtke AJ: Alterations in fatty acid oxidation in ischemice and reperfused myocardium. Mol Cell Biochem 88: 145-153, 1989
78. Wojtezak L, Schonfeld P: Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acts 1183: 41-57, 1993
79. Rottenberg H, Hashitnoto K: Fatty acid uncoupling of oxidative phosphorylation in rat liver mitochondria. Biochem 25: 1747-1755, 1986
80. Bush LR, Shlafer M, Haack DW, Lucchcsi BR: Time-dependent changes in canine cardiac mitochondrial function and ultrastructure resulting from coronary occlusion and reperfusion. Bas Res Cardiol 75: 555-571, 1980
81. Wojtczak L, Bogucka K, Sarzala MG, Zaluska H: Effect of fatty acids on energy metabolism and the transport of adeninc nucleotides in mitochondria and other cellular structures, In: L. Ernster and Z. Drahota (eds). Mitochondria, structure and function. Academic Press, New York, 1969, pp 79-92
82. Gutknecht J: Proton conductance caused by long-chain fatty acids in phospholipid bilayer membranes. J Membr Biol 106: 83-93, 1988
83. Schonfcld P, Schild L, Kunz W. Long-chain fatty acids act as protonophoric uncouplers of oxidative phosphorylation in rat liver mitochondria. Biochim Biophys Acta 977: 266-272, 1989
84. Andreyev AY, Bondareva TO, Dedukhova VI, Mokhova EN, Skulachev VP, Tsofina LM, Volkov NI, Vygodina TV: The ATP/ ADP-antiporter is involved in the uncoupling effect of fatty acids on mitochondria. Eur J Biochem. 182: 585-592, 1989
85. Van Bilsen M, van der Vasse GJ, Willemsen PHM, Coumans WA, Roemen THM, Reneman RS: Lipid alterations in isolated, working rat hearts during ischemia and reperfusion: its relation to myocardial damage. Circ Res 64: 304-314, 1989
86. Vikmo H, Mjos OD, Noely JR, Maroko PR, Ribiero LGT: Limi tation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium. Am Heart J 111: 1048-1054, 1986
87. Liedtke AJ, Nellis SH, Mjos OD; Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 247: H3S7-H394, 1984
88. Shikama H, Noshiro O, Ohta A, Ohata I: Effects of acylcarnitine transferase inhibitors on adenine nucleotide metabolism and ischemic tissue injury in isolated perfused rat hearts, Jpn Heart J 29: 723-734, 1988
89. Hekimian G, Feuvray D: Reduction of ischemia-induced acylcarnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts. Diabetes 35: 906-910, 1986
90. Renstrom B, Nellis SH, Liedtke AJ: Metabolic oxidation of glucose during early myocardial reperfusion. Circ Res 65: 1094-1111, 1989
91. Mjos OD, Miller NE, Ricmersma RA, Oliver MF: Effects of dichloroacetate on myocardial substrate extraction, epicardial ST-segment elevation, and ventricular blood flow following coronary occlusion in dogs. Cardiovase Res 10: 427-436, 1976
92. Mjos OD, Ichihara K, Fellenius E, Myrmel T, Neely JR: Fatty acids suppress recovery of heart function after hypothermic perfusion. Ann Thor Surg 52: 965-970, 1991
93. Bachmann E, Weber E: Biochemical mechanisms of oxfenicine cardiotoxicity. Pharmacology 36: 238-248, 1988
94. Greaves P, Martin J, Michel MC, Mompon P: Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism. Arch Toxicol Suppl.7: 488-493, 1984
95. Litwin SE, Raya, TE, Gay RG, Bedotto JB, Bahl JJ, Anderson PG, Goldman S, Bressler R: Chronic inhibition of fatty acid oxidation: a new model of diastolic dysfunction. Am J Physiol 258: H51-H56, 1990
96. Reinhauer H, Adrian M, Rosen P, Schmilz F-J: Influence of carnitinc acyltrflnsferase i nhibitors on the performance and metabolism of rat cardiac muscle. J Clin Chem Clin Biochem 28: 335-339, 1990
97. Bergman G, Atkinson L, Metcalfe J, Jackson N, Jewitt DE: Beneficial effect of enhanced carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) i n angina pectoris. Eur Heart J 1: 247-253, 1980